4.2 Letter

Computational-based drug repurposing methods in COVID-19

Journal

BIOIMPACTS
Volume 10, Issue 3, Pages 205-206

Publisher

TABRIZ UNIV MEDICAL SCIENCES & HEALTH SERVICES
DOI: 10.34172/bi.2020.25

Keywords

COVID-19; Drug repurposing; In silico drug discovery

Ask authors/readers for more resources

COVID-19, as a newly emerging disease, has disrupted human's different activities. Hence, it is essential to develop drugs or vaccines in order to control COVID-19. Since there is not a medication or vaccine for treating the disease and drug development project is a time and cost consuming process, drug repurposing approaches may yield to proper curing plans. However, there are some limitations in this field, which make the process a challenging one. This letter aims to introduce drug repurposing methods and the existing challenges to detect candidate drugs which may be helpful in controlling COVID-19.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available